Interleukin 9 serum level and single nucleotide polymorphism in patients with asthma.

ABSTRACT:

Background

Asthma is a chronic inflammatory disease of airways which accounts for a huge economic, morbidity and mortality burden. There are different cytokines that contribute to asthma pathophysiology. Learning about these cytokines leads to attaining novel anti-inflammatory treatments for asthma control.

Objectives

The objective of this study is to investigate the association between interleukin-9 serum level and gene polymorphism with asthma susceptibility.

Methods

This was a case-control study of 70 asthmatic patients and 77 healthy control adults aged 18-60. Asthma diagnosis and severity were based on physician diagnosis, pulmonary function test (PFT) and 2016 guild line of Global Initiative for Asthma (GINA). Interleukin 9(IL -9) serum level was measured using

SUBMITTER: Mahdaviani SA 

PROVIDER: S-EPMC8343737 | biostudies-literature | 2021 Jul

REPOSITORIES: biostudies-literature